Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice
基因修饰小鼠 MI 后左心室重塑的多参数 CMR
基本信息
- 批准号:9065605
- 负责人:
- 金额:$ 38.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdenosineAgonistAnimal ExperimentationAnti-Inflammatory AgentsAnti-inflammatoryBiomedical ResearchBone Marrow TransplantationCD4 Positive T LymphocytesCardiacCardiologyCause of DeathCellsCessation of lifeCine Magnetic Resonance ImagingClinical TrialsCoronary OcclusionsDevelopmentDiagnosisEdemaEvaluationFeedbackFoundationsFunctional disorderFutureGadoliniumGene ProteinsGene-ModifiedGenesGenetically Engineered MouseHealthHeartHeart failureHourImageImaging TechniquesImmune systemIndividualInfarctionInfiltrationInflammationInflammatoryInflammatory ResponseKineticsKnock-outKnockout MiceLabelLeftLeft Ventricular FunctionLeft Ventricular RemodelingLiposomesLiteratureLocationMagnetic ResonanceMagnetic Resonance ImagingMapsMeasuresMechanicsMediatingMediator of activation proteinMethodsMolecularMolecular GeneticsMorbidity - disease rateMusMyocardialMyocardial InfarctionMyocardial IschemiaMyocardial perfusionPathway interactionsPerfusionPlayPreventionPrevention therapyPrincipal InvestigatorProcessRadiology SpecialtyReceptor ActivationReceptor GeneReceptor SignalingRecoveryRegional PerfusionResearchResearch PersonnelResearch Project GrantsRoleSecondary toShapesSignal PathwaySignal TransductionSystemT-LymphocyteTechniquesTestingTissuesTransgenic MiceUnited StatesVentricularWeightWorkWound Healingcell typecontrast enhancedgadolinium oxidegenetic manipulationheart cellimmunopathologyin vivoinsightinterdisciplinary approachmacrophagemolecular/cellular imagingmonocytemortalitymouse modelpersonalized carereceptorresearch studyresponsesmall moleculespatiotemporaltooltreatment strategy
项目摘要
DESCRIPTION (provided by applicant): The central premise of this application is that the combination of multi-parameter cardiac magnetic resonance (CMR) and advanced genetic manipulations in mice holds considerable potential for unraveling the molecular mechanisms underlying left ventricular (LV) remodeling due to myocardial infarction (MI). Previous work from the Principal Investigator shows that adenosine 2A receptor (A2AR) agonists can reduce infarct size and preserve cardiac function through T-cell mediated pathways. This application proposes to apply multi-parameter CMR to genetically-modified mice to address the hypothesis that related mechanisms may contribute importantly to LV remodeling after reperfused MI. In these studies, a multidisciplinary approach will be used that spans the fields of radiology, cardiology, immunopathology & molecular genetics. The specific aims are to: 1) Apply multi-parameter CMR to test the hypothesis that adenosine 2A receptor (A2AR) signaling, which will be pharmacologically enhanced or genetically ablated, modifies LV remodeling and regional 3D strain, as well as macrophage activity and recovery of perfusion in the infarct zone. In preliminary studies, our team has shown that global LV remodeling is dramatically reduced by A2AR activation. In this Aim, 3D myocardial mechanics will be assessed by 3D cine DENSE, macrophage infiltration by T1 mapping of Gd-liposomes, regional perfusion by first-pass kinetics and infarct size/location by late gadolinium enhanced (LGE) CMR. These imaging techniques will be applied serially in the settings of both A2AR activation and gene knock-out to define the role of A2AR signaling in the spatiotemporal relationships that exist between these critical parameters. 2) Develop T2 mapping for quantifying myocardial edema and apply it to test the hypothesis that the kinetics of myocardial edema surrounding the infarct zone are modulated by A2AR signaling, both in the settings of LV remodeling and myocardial salvage. The essential role of A2AR signaling as a negative feedback mechanism for resolving inflammation leads us to hypothesize that A2AR agonists curtail both infarct expansion and LV remodeling by mechanisms that should also resolve edema. Here, T2 mapping will be developed and used to serially assess regional edema in mouse models of both LV remodeling (60 min reperfused coronary occlusion) and myocardial salvage (20 min occlusion) to test the hypothesis that edema will resolve more quickly in mice treated with an A2AR agonist. Conversely, post-MI edema should be aggravated in A2AR-/- mice. 3) Apply select combinations of advanced CMR techniques and gene modified mice to determine whether the efficacious A2AR signaling occurs in inflammatory cells or in other cell types. Here, we propose to use bone marrow transplantation to generate chimeric mice where A2AR signaling is selectively abolished in either the cells of the heart or in the inflammatory system. The results of these experiments will not only clarify the relative importance of A2AR signaling in these two tissue compartments, they will guide future studies focused on elucidating the role(s) of these mechanism(s) in curtailing the LV remodeling response.
描述(申请人提供):这项申请的中心前提是,多参数心脏磁共振(CMR)和先进的遗传操作相结合,在揭示心肌梗死(MI)导致的左心室(LV)重构的分子机制方面具有相当大的潜力。首席调查员先前的工作表明,腺苷2A受体(A2AR)激动剂可以通过T细胞介导的途径缩小心肌梗死面积并保护心功能。本申请建议将多参数CMR应用于转基因小鼠,以解决相关机制可能对再灌流MI后左室重构起重要作用的假说。在这些研究中,将使用跨越放射学、心脏病学、免疫病理学和分子遗传学领域的多学科方法。其具体目的是:1)应用多参数CMR来验证腺苷2A受体(A2AR)信号将被药物增强或基因消融,改变左室重构和局部3D应变,以及梗死区巨噬细胞活性和血流灌注恢复的假设。在初步研究中,我们的团队已经证明,A2AR的激活显著减少了全球左室重构。在这一目标中,三维心肌力学将通过3D电影致密、巨噬细胞浸润、Gd-脂质体T1图、首次通过动力学区域灌注和晚期Gd增强(LGE)CMR来评估梗塞范围/位置。这些成像技术将被连续应用于A2AR激活和基因敲除的环境中,以确定A2AR信号在这些关键参数之间存在的时空关系中的作用。2)建立T2图用于量化心肌水肿,并将其用于检验梗死区周围心肌水肿的动力学受A2AR信号调节的假说,在左心室重构和心肌挽救的背景下都是如此。A2AR信号作为消炎的负反馈机制的重要作用使我们假设A2AR激动剂通过也应该消除水肿的机制来抑制梗塞扩大和左室重构。在这里,T2标测图将被开发并用于连续评估LV重塑(60分钟再灌流冠状动脉闭塞)和心肌挽救(20分钟闭塞)的小鼠模型中的局部水肿,以测试A2AR激动剂治疗的小鼠的水肿将更快消退的假设。相反,在A2AR-/-小鼠中,心肌梗死后的水肿应该加重。3)应用先进的CMR技术和基因修饰小鼠的选择组合来确定有效的A2AR信号是发生在炎性细胞中还是发生在其他类型的细胞中。在这里,我们建议使用骨髓移植来产生嵌合小鼠,在这种嵌合小鼠中,A2AR信号在心脏细胞或炎症系统中选择性地被取消。这些实验结果不仅将阐明A2AR信号在这两个组织间隔中的相对重要性,而且将指导未来专注于阐明这些机制(S)在抑制左室重构反应中的作用(S)的未来研究。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brent A French其他文献
Pharmacologic immunomodulation via adenosine 2a receptor stimulation improves LV remodeling and systolic strain in regions adjacent to the infarct as assessed by cardiac MRI
- DOI:
10.1186/1532-429x-18-s1-o73 - 发表时间:
2016-01-27 - 期刊:
- 影响因子:
- 作者:
Ya-Jian Cheng;Elie R Chemaly;Yikui Tian;Frederick H Epstein;Brent A French - 通讯作者:
Brent A French
2093 CMR reveals that cardiac-specific overexpression of the inducible form of nitric oxide synthase induces Left Ventricular Hypertrophy in wild-type mice after AAV-Mediated direct gene transfer
- DOI:
10.1186/1532-429x-10-s1-a362 - 发表时间:
2008-10-22 - 期刊:
- 影响因子:
- 作者:
Konkal MR Prasad;Ronald J Beyers;Yaqin Xu;Frederick H Epstein;Brent A French - 通讯作者:
Brent A French
2091 Manganese enhanced mri demonstrates a predominant role for nNOS, not eNOS, in modulating L-Type calcium channel flux in the heart
- DOI:
10.1186/1532-429x-10-s1-a360 - 发表时间:
2008-10-22 - 期刊:
- 影响因子:
- 作者:
Moriel H Vandsburger;Brent A French;Patrick A Helm;Christopher M Kramer;Frederick H Epstein - 通讯作者:
Frederick H Epstein
Detection of increased coronary microvascular permeability with MRI T1 mapping and gadolinium-labeled albumin
- DOI:
10.1186/1532-429x-18-s1-w3 - 发表时间:
2016-01-27 - 期刊:
- 影响因子:
- 作者:
Sophia X Cui;Brent A French;Frederick H Epstein - 通讯作者:
Frederick H Epstein
Brent A French的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brent A French', 18)}}的其他基金
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
光学成像在开发用于心肌梗塞后心脏再生的分子靶向 AAV 中
- 批准号:
10395499 - 财政年份:2019
- 资助金额:
$ 38.41万 - 项目类别:
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
光学成像在开发用于心肌梗塞后心脏再生的分子靶向 AAV 中
- 批准号:
9903440 - 财政年份:2019
- 资助金额:
$ 38.41万 - 项目类别:
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
用于靶向胰腺癌的高度特异性和高效的载体
- 批准号:
8775439 - 财政年份:2014
- 资助金额:
$ 38.41万 - 项目类别:
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice
基因修饰小鼠 MI 后左心室重构的多参数 CMR
- 批准号:
8504366 - 财政年份:2013
- 资助金额:
$ 38.41万 - 项目类别:
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice
基因修饰小鼠 MI 后左心室重塑的多参数 CMR
- 批准号:
8858407 - 财政年份:2013
- 资助金额:
$ 38.41万 - 项目类别:
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice
基因修饰小鼠 MI 后左心室重塑的多参数 CMR
- 批准号:
8685318 - 财政年份:2013
- 资助金额:
$ 38.41万 - 项目类别:
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size
梗塞面积高血糖恶化中的炎症和氧化应激
- 批准号:
8495393 - 财政年份:2009
- 资助金额:
$ 38.41万 - 项目类别:
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size
梗塞面积高血糖恶化中的炎症和氧化应激
- 批准号:
7900419 - 财政年份:2009
- 资助金额:
$ 38.41万 - 项目类别:
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size
梗塞面积高血糖恶化中的炎症和氧化应激
- 批准号:
7730598 - 财政年份:2009
- 资助金额:
$ 38.41万 - 项目类别:
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size
梗塞面积高血糖恶化中的炎症和氧化应激
- 批准号:
8284413 - 财政年份:2009
- 资助金额:
$ 38.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.41万 - 项目类别:
Research Grant